Neuren Pharmaceuticals Ltd. (NURPF)
8.825
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Neuren Pharmaceuticals Market Cap : 1.116B for April 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kazia Therapeutics Ltd. | 155.86M |
| Immutep Ltd. | 67.29M |
| Algorae Pharmaceuticals Ltd. | 13.53M |
| Starpharma Holdings Ltd. | 195.31M |
| CSL Ltd. | 21.86B |
Market Cap Related Metrics
| PE Ratio | 58.79 |
| PS Ratio | 27.63 |
| Price to Free Cash Flow | 14.05 |
| Price | 8.825 |
| Earnings Yield | 1.70% |
| Operating PE Ratio | 81.25 |
| Normalized PE Ratio | 54.68 |